Share on StockTwits

Wright Medical Group (NASDAQ:WMGI) CFO Lance A. Berry sold 2,135 shares of the company’s stock in a transaction dated Thursday, May 15th. The shares were sold at an average price of $29.30, for a total transaction of $62,555.50. Following the completion of the sale, the chief financial officer now directly owns 68,665 shares in the company, valued at approximately $2,011,885. The transaction was disclosed in a filing with the SEC, which is available at this link.

Wright Medical Group (NASDAQ:WMGI) traded up 2.23% during mid-day trading on Friday, hitting $29.595. The stock had a trading volume of 582,142 shares. Wright Medical Group has a 52 week low of $23.45 and a 52 week high of $33.80. The stock’s 50-day moving average is $29.2 and its 200-day moving average is $30.11. The company’s market cap is $1.439 billion.

Wright Medical Group (NASDAQ:WMGI) last posted its quarterly earnings results on Wednesday, April 30th. The company reported ($0.34) EPS for the quarter, beating the Thomson Reuters consensus estimate of ($0.42) by $0.08. The company had revenue of $71.10 million for the quarter, compared to the consensus estimate of $69.49 million. Analysts expect that Wright Medical Group will post $-1.32 EPS for the current fiscal year.

A number of research firms have recently commented on WMGI. Analysts at Leerink Swann reiterated an “outperform” rating on shares of Wright Medical Group in a research note on Thursday, May 1st. They now have a $37.00 price target on the stock. Separately, analysts at Brean Capital raised their price target on shares of Wright Medical Group from $37.00 to $40.00 in a research note on Thursday, May 1st. They now have a “buy” rating on the stock. Finally, analysts at Needham & Company LLC upgraded shares of Wright Medical Group from a “buy” rating to a “strong-buy” rating in a research note on Thursday, May 1st. They now have a $40.00 price target on the stock. Four investment analysts have rated the stock with a hold rating, four have issued a buy rating and one has given a strong buy rating to the stock. The stock currently has an average rating of “Buy” and a consensus target price of $35.18.

Wright Medical Group, Inc through Wright Medical Technology, Inc (NASDAQ:WMGI) and other operating subsidiaries (Wright), is a global orthopaedic medical device company specializing in the design, manufacture and marketing of devices and biologic products for extremity, hip and knee repair and reconstruction.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.